drugset / Trial / NCT00932945

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal

NCT00932945

Phase 3 Completed 32 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Primary Objective: To prove the safety of the gynecological formulation in normal conditions of use.

Timeline

Start
2009-06
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified

Indications

No indication recorded.